Editorial
Predicting fatalities in serious idiosyncratic drug-induced liver injury—a matter of choosing the best Hy’s law
Abstract
The field of hepatotoxicity presents various interesting investigational challenging areas, such as pharmacogenetics and qualification through biomarkers. The ultimate goal is to achieve a true impact in the diagnosis of drug-induced liver injury (DILI) in clinical practice.
